Stay updated on Risankizumab in PsA Patients: Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in PsA Patients: Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    KEEPSAKE page revision tag updated from v3.5.2 to v3.5.3, indicating a newer version of the page's documentation. This update is metadata-level and does not alter the trial details or substantive information presented.
    Difference
    0.0%
    Check dated 2026-04-30T08:39:35.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The facility location name in Latvia was changed from “Ādaži” to “Adazi” while retaining the same address/city details.
    Difference
    0.0%
    Check dated 2026-04-23T04:40:31.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T02:07:44.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-25T06:49:48.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-10T15:33:16.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    Minor website revision updates were made: Revision v3.4.2 was added and Revision v3.4.1 was removed. No user-facing content or study data were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-17T04:21:06.000Z thumbnail image

Stay in the know with updates to Risankizumab in PsA Patients: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.